Navigation Links
UGA discovery promises to improve drugs used to fight cancer, other diseases
Date:1/11/2013

Athens, Ga. Even when at rest, the human body is a flurry of activity. Like a microscopic metropolis locked in a state of perpetual rush hour traffic, the trillions of cells that make us who we are work feverishly policing the streets, making repairs, building new structures and delivering important cargo throughout the bustling organic society.

For everything to work properly there must be something to organize and direct the various workers. Enter protein kinases. Like specialized traffic signals, this huge class of proteins is critical for many aspects of cell communication, telling them when to begin work and when to stop.

Now, University of Georgia researchers have discovered that a little-studied part of the protein kinases that once appeared non-functional may actually control the most critical functions of the entire molecule. Their research promises to help improve drugs used to fight a variety of life-threatening diseases, from diabetes to cancer.

"The overall goal of this project was to better understand how these proteins function and what mechanisms control their function," said Natarajan Kannan, a Georgia Cancer Coalition Distinguished Scholar and assistant professor of biochemistry and molecular biology in the Franklin College of Arts and Sciences. "Our research shows that these little-studied dark regions of the protein are directly affecting the molecule's function."

Normally functioning protein kinases perform duties central to the everyday cellular operations within our bodies, but when they become dysfunctional, they can play a major role in the development of numerous serious diseases, including Alzheimer's, diabetes, cardiovascular disease and many forms of cancer.

Scientists have recognized the value of the proteins as therapeutic targets for decades, and numerous drugs, known as protein kinase inhibitors, are commonly prescribed in an attempt to slow or stop the rogue kinases that cause disease. The UGA team hopes its discovery will not only lead to new therapies but also help improve those already in existence.

"This opens a new front on the battle against many diseases, particularly cancer," said Krishnadev Oruganty, a postdoctoral research associate in biochemistry and molecular biology and lead author of a paper detailing the discovery published on Dec. 31 in the early edition of the Proceedings of the National Academy of Sciences USA.

Developing entirely new drugs is an extraordinarily lengthy and expensive process, but this new understanding of how protein kinases switch between "on" and "off" states will make it possible for researchers to modify existing drugs to make them perform better without significant investment.

"These are a very important class of proteins for biomedical industries, and the pharmaceutical industry has already invested billions of dollars in drugs that target these proteins," said Kannan, who is part of the UGA Cancer Center and the Institute of Bioinformatics. "This discovery will have a huge impact on how pharmaceutical companies develop drugs, because subtle modifications of these drugs will make it easier to control them, which will boost their effectiveness."

Kannan and the interdisciplinary team of UGA researchers working on the project are already beginning to design drugs that can selectively inhibit the rogue proteins that cause disease, but they caution that more research is needed to perfect their approach.

Nevertheless, they are confident that this discovery will have a profound impact on the pharmaceutical industry, and on the understanding of the elementary components of life.

"Every fundamental signaling pathway in our cells is controlled by these proteins," Kannan said. "Gaining a deeper understanding of how these kinases work will open doors to a myriad of important new discoveries."


'/>"/>

Contact: Natarajan Kannan
kannan@bmb.uga.edu
706-542-7326
University of Georgia
Source:Eurekalert

Related medicine news :

1. Life Sciences Discovery Fund makes grants to commercialize health-related technologies
2. Discovery in Ghent could improve screening for sudden cardiac death
3. UAlberta medical researchers make key discovery in fight against Alzheimers disease
4. DNA packaging discovery reveals principles by which CRC mutations may cause cancer
5. Pancreas stem cell discovery may lead to new diabetes treatments
6. New, improved mouse model of human Alzheimers may enable drug discovery
7. Cell death discovery suggests new ways to protect female fertility
8. Discovery of essential genes for drug-resistant bacteria reveals new, high-value drug targets
9. UGA chemistry discovery could have major medical implications
10. Astex, CRT and the Institute of Cancer Research announce epigenetic drug discovery collaboration
11. Genetic discovery in Montreal for a rare disease in Newfoundland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Whippany, New Jersey (PRWEB) , ... February 11, 2016 , ... ... invited to a free CEU seminar titled, “Stroke Management: Time to Act, Time to ... Senior Housing Community in Whippany, N.J. The presenter is Vishal Chedda, president of ...
(Date:2/11/2016)... ... February 11, 2016 , ... The president released a FY 2017 budget request ... shift more of the cost burden to military beneficiaries. , MOAA’s president, retired ... defense budget as including limited quantifiable benefit fixes mixed with numerous beneficiary fee hikes. ...
(Date:2/11/2016)... ... February 11, 2016 , ... In a new ... plastic surgeon , Dr. Rod J. Rohrich, and colleagues, examine and underscore the ... recommendations for rhinoplasty surgeons when addressing this vital area. , The upper lateral ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... of J.R. Garrett Esq. as General Counsel. Garrett will focus on contract negotiations, ... and audits, privacy and security law, and best practices in data breaches for ...
(Date:2/11/2016)... ... 11, 2016 , ... Talix today announced that Clive Fields, ... presenting at the 2016 HIMSS Annual Conference & Exhibition, taking place February 29 ... “ Coding for Care: Using Data Analytics for Risk Adjustment ,” Dr. Fields ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... Feb. 11, 2016 Wearable posture tracker, ALEX , has taken Kickstarter by storm, crowdfunding ... seven days left to go, ALEX is said to be delivered to backers starting May of this ... ... ... Created by NAMU, a ...
(Date:2/11/2016)... 11, 2016 Breast Cancer Therapeutics in ... Asia-Pacific (APAC) breast cancer market will experience ... by 2021, at a Compound Annual Growth Rate (CAGR) of ... to 2021 - states that the Asia-Pacific ... from $1.9 billion in 2014 to $3.4 billion by 2021, ...
(Date:2/11/2016)... 11, 2016 PLAD, Inc. (OTC Pink: PLAD) is ... sales exceeding company targets, are adding key personnel to ... from the United States Patent and Trademark Office for ... Executive Officer of PLAD, Inc.  In January, PLAD established ... with two new customers, Cumberland Goodwill EMS ...
Breaking Medicine Technology: